๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P61 The application of pharmacokinetic modeling to the predication of drug needs during multicenter clinical trials

โœ Scribed by Jamie G. Barnhill; Mark S. Jones; John H. Banker; Joanne Setnar


Book ID
113298551
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
75 KB
Volume
17
Category
Article
ISSN
0197-2456

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Utility of a physiologicallyโ€“based pharm
โœ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4

Advances in data assessment. Application
โœ Gary R. Morrow; Peter M. Black; Deborah J. Dudgeon ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 728 KB

Typical inferential statistical procedures, such as the t-test and analysis of variance, compare differences in mean values of variables. This approach can sometimes obscure rather than illuminate research data. Here we present and discuss alternative data analytic techniques. Potential advantages o